- Home
- BWLP vs ZLAB Comparison
BWLP vs ZLAB Comparison
Compare BWLP & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BWLP | ZLAB |
|---|---|---|
| Founded | 1935 | 2013 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | BWLP | ZLAB |
|---|---|---|
| Price | $12.49 | $17.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $57.22 |
| AVG Volume (30 Days) | 420.6K | ★ 1.0M |
| Earning Date | 12-02-2025 | 11-06-2025 |
| Dividend Yield | ★ 10.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $3,693,482,000.00 | $441,629,000.00 |
| Revenue This Year | N/A | $30.20 |
| Revenue Next Year | $4.24 | $34.71 |
| P/E Ratio | $11.08 | ★ N/A |
| Revenue Growth | 2.54 | ★ 24.14 |
| 52 Week Low | $7.86 | $16.82 |
| 52 Week High | $16.60 | $44.34 |
Technical Indicators
Market Signals| Indicator | BWLP | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 28.16 |
| Support Level | $12.31 | $16.82 |
| Resistance Level | $12.65 | $18.29 |
| Average True Range (ATR) | 0.23 | 0.63 |
| MACD | 0.06 | 0.19 |
| Stochastic Oscillator | 65.75 | 19.26 |
Price Performance
Historical ComparisonAbout BWLP BW LPG Limited
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.